ERYTECH gives feedback on its first Investor R&D Day and provides a financial and business update for Q4 2013 Post author:admERY Post published:January 27, 2014 Post category:Newsroom ERYTECH held its first Investor R&D day and provides a financial and business update for the fourth quarter of 2013. You Might Also Like ERYTECH strengthens its intellectual property position in the US April 21, 2015 ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer November 25, 2019 ERYTECH Announces Management Change January 4, 2016
ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer November 25, 2019
